Study Evaluating the Efficacy and Safety of Three Formulations of Ultra-low Dose Estriol Vaginal Gel (0.005%, 0.002%, 0.0008% Estriol Vaginal Gel) for the Treatment of Vaginal Dryness in Postmenopausal Women With Vulvovaginal Atrophy

Condition:   Vaginal Atrophy Interventions:   Drug: Estriol;   Drug: Placebo Sponsor:   ITF Research Pharma, S.L.U. Recruiting - verified November 2016
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials